Nectar Lifesciences Balance Sheet Health
Financial Health criteria checks 4/6
Nectar Lifesciences has a total shareholder equity of ₹10.7B and total debt of ₹6.8B, which brings its debt-to-equity ratio to 63.8%. Its total assets and total liabilities are ₹21.4B and ₹10.8B respectively. Nectar Lifesciences's EBIT is ₹618.2M making its interest coverage ratio 0.7. It has cash and short-term investments of ₹203.5M.
Key information
63.8%
Debt to equity ratio
₹6.81b
Debt
| Interest coverage ratio | 0.7x |
| Cash | ₹203.51m |
| Equity | ₹10.67b |
| Total liabilities | ₹10.75b |
| Total assets | ₹21.43b |
Recent financial health updates
Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?
Dec 22
Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?
Jun 16Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt
Jun 21Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt
Jul 29Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet
Jan 21Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?
Sep 07
Recent updates
Nectar Lifesciences Limited (NSE:NECLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Industry
Feb 19Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?
Dec 22Nectar Lifesciences (NSE:NECLIFE) Has Debt But No Earnings; Should You Worry?
Jun 16Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt
Jun 21Nectar Lifesciences (NSE:NECLIFE) Takes On Some Risk With Its Use Of Debt
Jul 29Is Nectar Lifesciences Limited (NSE:NECLIFE) A Risky Dividend Stock?
Feb 25Nectar Lifesciences (NSE:NECLIFE) Has A Somewhat Strained Balance Sheet
Jan 21Zooming in on NSE:NECLIFE's 0.3% Dividend Yield
Nov 02Does Nectar Lifesciences (NSE:NECLIFE) Have A Healthy Balance Sheet?
Sep 07If You Had Bought Nectar Lifesciences (NSE:NECLIFE) Stock A Year Ago, You Could Pocket A 47% Gain Today
Aug 09The Nectar Lifesciences (NSE:NECLIFE) Share Price Has Gained 47% And Shareholders Are Hoping For More
Aug 09What You Can Learn From Nectar Lifesciences Limited's (NSE:NECLIFE) P/E
Jul 13Financial Position Analysis
Short Term Liabilities: NECLIFE's short term assets (₹12.1B) exceed its short term liabilities (₹8.8B).
Long Term Liabilities: NECLIFE's short term assets (₹12.1B) exceed its long term liabilities (₹1.9B).
Debt to Equity History and Analysis
Debt Level: NECLIFE's net debt to equity ratio (61.9%) is considered high.
Reducing Debt: NECLIFE's debt to equity ratio has reduced from 83.8% to 63.8% over the past 5 years.
Debt Coverage: NECLIFE's debt is well covered by operating cash flow (25.9%).
Interest Coverage: NECLIFE's interest payments on its debt are not well covered by EBIT (0.7x coverage).